Wang C - Search Results

1

Coronary CT Angiography-based Morphologic Index for Predicting Hemodynamically Significant Coronary Stenosis.

Wang C, Leng S, Tan RS, Chai P, Fam JM, Teo LLS, Chin CY, Ong CC, Baskaran L, Keng YJF, Low AFH, Chan MY, Wong ASL, Chua SJT, Wu Q, Tan SY, Lim ST, Zhong L. Wang C, et al. Radiol Cardiothorac Imaging. 2023 Dec;5(6):e230064. doi: 10.1148/ryct.230064. Radiol Cardiothorac Imaging. 2023. PMID: 38166346

2

Efficacy and Safety of LCZ696 for Short-term Management of Essential Hypertension Compared With ARBs: A Meta-analysis of Randomized Controlled Trials.

Yang S, Zhang H, Yang P, Wang C, Wu Q. Yang S, et al. Among authors: wang c. J Cardiovasc Pharmacol. 2021 May 1;77(5):650-659. doi: 10.1097/FJC.0000000000001001. J Cardiovasc Pharmacol. 2021. PMID: 33951700

3

Development and validation of a deep learning model to screen hypokalemia from electrocardiogram in emergency patients.

Wang CX, Zhang YC, Kong QL, Wu ZX, Yang PP, Zhu CH, Chen SL, Wu T, Wu QH, Chen Q. Wang CX, et al. Chin Med J (Engl). 2021 Sep 2;134(19):2333-2339. doi: 10.1097/CM9.0000000000001650. Chin Med J (Engl). 2021. PMID: 34483253 Free PMC article.

4

[A case of pseudo heart disease].

Huang MX, Liu YN, Wang CX, Wu QH. Huang MX, et al. Among authors: wang cx. Zhonghua Nei Ke Za Zhi. 2019 Mar 1;58(3):217-219. doi: 10.3760/cma.j.issn.0578-1426.2019.03.014. Zhonghua Nei Ke Za Zhi. 2019. PMID: 30803183 Chinese.

5

Efficacy and Safety of Finerenone for Prevention of Cardiovascular Events in Type 2 Diabetes Mellitus With Chronic Kidney Disease: A Meta-analysis of Randomized Controlled Trials.

Yang S, Shen W, Zhang HZ, Wang CX, Yu WQ, Wu QH. Yang S, et al. J Cardiovasc Pharmacol. 2023 Jan 1;81(1):55-62. doi: 10.1097/FJC.0000000000001364. J Cardiovasc Pharmacol. 2023. PMID: 36027585

6

[Efficacy and safety of non-vitamin K antagonist versus vitamin K antagonist oral anticoagulants in the prevention and treatment of thrombotic disease in active cancer patients: a systematic review and meta-analysis of randomized controlled trials].

Wang CX, Wu D, Yang PP, Wu QH. Wang CX, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Aug 24;48(8):689-696. doi: 10.3760/cma.j.cn112148-20200630-00529. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32847326 Chinese.

7

Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials.

Yang S, Shen W, Zhang HZ, Wang CX, Yang PP, Wu QH. Yang S, et al. Cardiovasc Drugs Ther. 2023 Oct;37(5):927-940. doi: 10.1007/s10557-022-07338-8. Epub 2022 May 5. Cardiovasc Drugs Ther. 2023. PMID: 35511323

8

Knockdown of ZFAS1 improved the cardiac function of myocardial infarction rats via regulating Wnt/β-catenin signaling pathway.

Zou B, Huang T, Wu D, Hu X, Xiao L, Wang C, Zhang H, Xiang J, Hu C, Wu Q, Wu T. Zou B, et al. Among authors: wang c. Aging (Albany NY). 2021 May 5;13(9):12919-12928. doi: 10.18632/aging.202961. Epub 2021 May 5. Aging (Albany NY). 2021. PMID: 33952724 Free PMC article.

9

Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation.

Yang P, Wang C, Ye Y, Huang T, Yang S, Shen W, Xu G, Wu Q. Yang P, et al. Among authors: wang c. Cardiovasc Drugs Ther. 2020 Jun;34(3):371-381. doi: 10.1007/s10557-020-06967-1. Cardiovasc Drugs Ther. 2020. PMID: 32232617

10

Efficacy and safety of oral anticoagulants in atrial fibrillation patients with cancer-a network meta-analysis.

Yang P, Zhu D, Xu X, Shen W, Wang C, Jiang Y, Xu G, Wu Q. Yang P, et al. Among authors: wang c. Heart Fail Rev. 2020 Sep;25(5):823-831. doi: 10.1007/s10741-019-09844-8. Heart Fail Rev. 2020. PMID: 31410758 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102,171 results

Search Page